Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial session on understanding the current scenario of cancer. This presentation will provide a detailed overview of the incidence of cancer in men, focusing on prevalent trends, key risk factors, and the importance of early detection. Globally, cancer is a leading cause of death, and its burden on men varies significantly by region and lifestyle. Understanding the most common cancers that affect men, such as prostate, lung, and colorectal cancer, is essential for developing effective prevention and screening strategies.
The current landscape of cancer in men is characterized by the dominance of a few specific types. In many parts of the world, prostate cancer is the most frequently diagnosed cancer, while lung and bronchus cancer remains the leading cause of cancer-related deaths. Other common malignancies include colorectal cancer, oral cancer, and head and neck cancers, which are often linked to modifiable risk factors like tobacco use and alcohol consumption. A deeper look at the incidence data reveals geographical disparities, with certain regions showing higher rates of specific cancers due to unique environmental, genetic, and lifestyle factors.
Therefore, get an overall knowledge of the current scenario of cancer incidence in men. Listen to the webinar, led by Dr. Ashish Singh, absorb the shared knowledge on the latest trends and diagnostic advancements, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
The Boom in ADHD Coaching Has Few Rules
2.
Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.
3.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
4.
Medicaid expansion tied to smaller declines in early-stage cancer detection
5.
Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma
1.
Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
4.
Unpacking the Importance of White Blood Cells (WBCs) in the Body
5.
Essential Updates in Hematology in Daily Practice
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation